Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 18, 2022, Michael Farkas informed Balance Labs, Inc. (the "Company") of
his intention to resign as Chief Financial Officer ("CFO"), effective as of July
18, 2022 (the "Separation Date"). Mr. Farkas resignation as CFO was not because
of any disagreement with the Company on any matter relating to the Company's
operations, policies or practices, including accounting principles and
practices. Mr. Farkas will continue to serve in his roles as the Company's
President, Chief Executive Officer, and Chairman of the Board.
On July 18, 2022, the Board of Directors of the Company (the "Board") appointed
Ari Feldman (age 49) to serve as the Company's CFO, effective July 18, 2022 (the
"Commencement Date"). Over the past five years, Mr. Feldman has served as a CFO
consultant.
In connection with the appointment, Mr. Feldman will receive $21,000 annually,
as compensation for his duties as CFO of the Company. Mr. Feldman will serve as
CFO until his earlier death, resignation, or removal.
There is no arrangement or understanding between Mr. Feldman and any other
persons, pursuant to which he was selected as CFO. Mr. Feldman has not engaged
in any transaction, or any currently proposed transaction, in which the Company
was or is to be a participant and the amount involved exceeds $120,000, and in
which any related person had or will have a direct or indirect material
interest. There is no employment agreement between Mr. Feldman and the Company.
There are no family relationships between Mr. Feldman and any director or
executive officer of the Company.
1
Item 9.01 Financial Statement and Exhibits.
(d) Exhibits
Exhibit Number Description of Document
104 Cover page of this Current Report on Form 8-K formatted in Inline
XBRL
2© Edgar Online, source Glimpses
BALANCE LABS, INC. 
